T2EVOLVE
Description
        
              
                  
                    Accelerating development and improving access to CAR and TCR-engineered T cell therapy
                
            
        
    Accession number
        
              
                  
                    c8c90cbe-c98a-11ed-a11d-ea435b63c148
                
            
        
    Project acronym
        
              
                  
                    T2EVOLVE
                
            
        
    Project website
        
    Start date
        
              
                  
                    2021-01-01
                
            
        
    End date
        
              
                  
                    2025-12-31
                
            
        
    Funding
        
              
                  
                    IMI2 - Call 18 (Grant number 945393)
                
            
        
    Types